Submit to IEEE SBiND 2027: CHF 200 Best Paper Award and Special Issue Opportunity

Dear colleagues,
We are pleased to invite you to submit your research contributions to 
IEEE SBiND 2027, the ICASSP 2027 Satellite Workshop on Speech Biomarkers 
for Neurodegenerative Diseases: Signal Processing, Artificial 
Intelligence, and Clinical Translation.

The paper submission deadline has been extended to November 30, 2026!

The SBiND 2027 Best Paper Award, sponsored by MAKE journal, includes a 
CHF 200 prize. The winning authors will also be invited to submit a 
substantially extended version of their paper to the planned SBiND 
Special Issue in MAKE, with a full APC waiver if the manuscript is 
accepted for publication.

Additionally, authors of other selected high-quality workshop papers 
will also be invited to submit substantially extended and enhanced 
versions of their contributions to the Special Issue.

We warmly welcome contributions from researchers, clinicians, engineers, 
and practitioners working at the intersection of speech and signal 
processing, artificial intelligence, neurology, clinical neuroscience, 
biomedical engineering, and digital health.

SBiND 2027 will take place on May 17, 2027, in Toronto, Canada, in 
conjunction with the 2027 IEEE International Conference on Acoustics, 
Speech, and Signal Processing (ICASSP 2027).

Kind regards,
The SBiND 2027 Organizing Committee

===============================================================
SBiND 2027
Speech Biomarkers for Neurodegenerative Diseases: Signal Processing, 
Artificial Intelligence, and Clinical Translation
May 17, 2027 – Toronto, Canada
https://www.sbind.icar.cnr.it/

Satellite Workshop of the 2027 IEEE International Conference on 
Acoustics, Speech, and Signal Processing – ICASSP 2027

Submit your paper: 
https://cmsworkshops.com/ICASSP2027/papers/submission.asp?ID=7&Type=WS
===============================================================

MISSION:
Neurodegenerative diseases such as Amyotrophic Lateral Sclerosis, 
Parkinson’s disease, and Alzheimer’s disease progressively affect speech 
production through changes in motor control, cognition, language, and 
respiratory function. Speech and voice therefore represent promising 
non-invasive and easily accessible biomarkers for supporting disease 
assessment, monitoring progression, and evaluating treatment response.
SBiND 2027 aims to bring together researchers, clinicians, engineers, 
and industry professionals working on speech and voice biomarkers for 
neurodegenerative diseases. The workshop will promote interdisciplinary 
discussion on the development of reliable signal-processing and 
artificial-intelligence methods and their translation into clinically 
meaningful and deployable solutions.
Building on previous research and challenge-based initiatives in this 
field, SBiND will address the methodological, clinical, and 
technological barriers that currently limit the generalizability, 
interpretability, reproducibility, and real-world adoption of 
speech-based biomarkers.
The workshop will include contributed papers, invited talks, and a 
multidisciplinary panel, providing a forum for sharing recent advances, 
clinical perspectives, open challenges, and future research directions.

TOPICS:
Topics of interest include, but are not limited to:
• Speech and voice biomarkers for neurodegenerative diseases
• Speech signal processing for neurological assessment and monitoring
• Acoustic, phonetic, prosodic, linguistic, and conversational biomarkers
• Artificial intelligence and machine learning for speech-based assessment
• Deep learning, self-supervised learning, and foundation models
• Automatic detection, classification, and differential diagnosis
• Longitudinal modelling and disease-progression prediction
• Multilingual, cross-lingual, and cross-corpus generalization
• Domain adaptation and robust learning across recording conditions
• Explainable and clinically interpretable artificial intelligence
• Multimodal integration of speech, language, clinical, imaging, and 
sensor data
• Digital phenotyping and remote patient monitoring
• Mobile, wearable, and telemedicine solutions for speech assessment
• Data quality, annotation protocols, and dataset harmonization
• Privacy-preserving learning and secure health-data processing
• Federated learning for distributed clinical data
• Bias, fairness, ethics, and responsible AI in clinical applications
• Reproducibility, benchmarking, and open science
• Clinical validation and real-world deployment
• Human-centred technologies and clinician–AI collaboration
• Regulatory and translational challenges for speech-based digital 
biomarkers

IMPORTANT DATES:
• EXTENDED paper submission deadline: November 30, 2026 (previously 
November 11, 2026)
• EXTENDED notification of paper acceptance: December 31, 2026 
(previously December 16, 2026)
• Camera-ready paper submission: January 27, 2027
• Workshop date: May 17, 2027

PAPER SUBMISSION:
Authors are invited to submit original research contributions addressing 
the workshop topics.
Submitted papers must follow the ICASSP 2027 paper style, formatting, 
and length requirements. Papers may contain a maximum of four pages of 
technical content, including figures and references, with an optional 
fifth page containing references only.
Papers must be submitted through the official ICASSP 2027 Satellite 
Workshop submission system:
https://cmsworkshops.com/ICASSP2027/papers/submission.asp?ID=7&Type=WS
All submissions will undergo a rigorous peer-review process managed 
independently by the SBiND 2027 Technical Program Committee.
Accepted and presented papers will be published in the IEEE Xplore 
Digital Library under a separate ICASSP 2027 Satellite Workshop record 
number.
At least one author of each accepted paper must register for the 
workshop and present the paper in person. Papers that are not presented 
in accordance with the conference policies will be withdrawn from the 
official proceedings.

BEST PAPER AWARD:
The SBiND 2027 Best Paper Award, sponsored by MAKE journal, includes a 
CHF 200 prize and a certificate. The winning contribution will be 
selected by the Workshop Chairs based on scientific significance, 
originality, methodological quality, clinical relevance, and the 
evaluations of the Technical Program Committee.
The winning authors will also be invited to submit a substantially 
extended version of their paper to the planned SBiND Special Issue in 
MAKE with a full APC waiver. The extended manuscript will undergo MAKE’s 
standard independent peer-review and editorial process. The APC waiver 
applies if the manuscript is accepted for publication.

SPECIAL ISSUE:
A dedicated SBiND Special Issue is planned in MAKE – Machine Learning 
and Knowledge Extraction journal.
Authors of selected high-quality papers presented at the workshop will 
be invited to submit substantially extended and enhanced versions of 
their contributions. Extended submissions must include significant new 
material beyond the workshop paper and will be treated as new journal 
manuscripts.
An invitation to submit does not guarantee acceptance. All extended 
manuscripts will undergo the journal’s standard independent peer-review 
and editorial process. The Special Issue title, scope, deadlines, and 
Guest Editor team will be announced soon.

CONTACT:
For further information, please visit: https://www.sbind.icar.cnr.it/
For questions, please contact: sbind@icar.cnr.it

-- 


        Dr. Giovanna Sannino
        Senior Researcher
        Head of AI-ISA Research Group - www.ai-isa.icar.cnr.it
        <https://www.ai-isa.icar.cnr.it>
        Italian Science Fund (FIS) Grant Awardee

        Institute for High-Performance Computing and Networking (ICAR)
        National Research Council of Italy (CNR)
        Via P. Castellino 111, 80131 Naples, Italy

        Executive Editor of Biomedical Signal Processing and Control
        Associate Editor of IEEE Transactions on Affective Computing
        Associate Editor of Applied Soft Computing
        Editor of Engineering Applications of Artificial Intelligence<

        Connect with me on LinkedIn
        <https://www.linkedin.com/in/giovannasannino/>

Received on Thursday, 12 November 2026 08:11:30 UTC